Teva Scrambles to Block Approval for Biogen's Copaxone Rival

Files citizen's petition and warns that Biogen Idec itself revealed troubling information about potential side effects of MS therapy BG-12.

Yoram Gabison
Yoram Gabison
Send in e-mailSend in e-mail
Yoram Gabison
Yoram Gabison

Comments